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Toward an International Constitution of
Patient Rights
ALISON PODLASKI*
ABSTRACT
In the past decade, medical tourism-the travel of patients across
borders to receive medical treatment-has undergone unprecedented
growth, fueled by the globalization of health care and related industries.
While medical tourism can benefit patients through increased access to
treatment and cost-savings, medical travel also raises concerns about
ensuring quality of care and legal redress in medical malpractice.
Moreover, existing regulations fail to address these unprecedented issues.
The multilateral adoption of an International Constitution of Patient
Rights (ICPR) is necessary in order to more effectively preserve medical
tourism's benefits and guard against its risks.
INTRODUCTION
Vince Ellis is a medical tourism success story.' The fifty-eight-year-
old U.S. citizen needed knee replacement surgery, but the high cost of
medical care in the United States was daunting, and even with
insurance through his employer, he faced a sizeable deductible
payment.2 Instead, his employer sent him to Costa Rica, where he
received a knee replacement-along with a luxury vacation package-at
* Notes Editor, Indiana Journal of Global Legal Studies; J.D. Candidate, 2016, Indiana
University Maurer School of Law; B.A., 2013, University of Notre Dame. I would like to
thank Professor Jody L. Madeira for sparking my interest in medical tourism and for her
guidance throughout the process of researching and writing this Note.
1. Beth Howard, Should You Have Surgery Abroad?, AARP MAG. (Oct./Nov. 2014),
http://www.aarp.org/health/conditions-treatments/info- 2014/medical-tourism -surgery-
abroad.html.
2. See id.
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a far cheaper price than he would have paid domestically. 3 He returned
home without complications and is now pain-free and back to work.4
Howard Staab was in desperate need of cardiac surgery to repair a
failing mitral valve. 5 But as an uninsured carpenter from North
Carolina, he could never afford to pay its cost-over $200,000 with a
mandatory 50 percent down payment-for the procedure in the United
States.6 Instead, he traveled to India, where he received the same
procedure for only $6,700.7 In 2006, Staab testified before Congress
about his experience. Media coverage of Staab's experience in India
depicted his procedure as a cost-efficient and life-saving success.8 Yet
little attention was paid to the challenges Staab encountered
attempting to receive treatment domestically when he fruitlessly
bargained with U.S. hospitals for a reduced rate.9 Moreover, news
stories glossed over the postsurgery complications Staab experienced
that required him to undergo another surgical procedure and extend his
stay in India, as well as the accompanying physical, emotional, and
financial stress.
Joy Williams, a twenty-four-year-old British woman, traveled to
Thailand in October 2014 for cosmetic tailbone surgery to correct a
previous procedure. 10 She had planned to save money by having the
surgery done abroad rather than in Britain. 1 As part of the routine
procedure, she was given an intravenous anesthetic. 12 Unfortunately,
she suddenly stopped breathing while under the anesthetic and died,
3. Id.
4. Id.
5. The Globalization of Health Care: Can Medical Tourism Reduce Health Care
Costs?: Hearing Before the Spec. Comm. on Aging, 109th Cong. 2-3 (2006) [hereinafter
Senate Hearing] (statement of Maggi Ann Grace, Patient Advocate).
6. Id.
7. Id.
8. John Lancaster, Surgeries, Side Trips for 'Medical Tourists': Affordable Care at
India's Private Hospitals Draws Growing Number of Foreigners, WASH. POST FOREIGN
SERVICE, Oct. 21, 2004, at A01, available at http://www.washingtonpost.com/wp-
dyn/articles/A49743-20040ct20.html; see also Kerrie S. Howze, Medical Tourism:
Symptom or Cure?, 41 GA. L. REV. 1013, 1051 (2007) (discussing Howard Staab's
experience as a medical tourist).
9. Howze, supra note 8, at 1051; see also Lancaster, supra note 8, at A01.
10. Jonathan Pearlman, British Woman, 24, Dies During Cosmetic Surgery in
Bangkok, THE TELEGRAPH (Oct. 25, 2014, 11:20 AM), http://www.telegraph.co.uklnews
worldnews/asia/thailand 11185204/British-woman-dies-during-cosmetic-surgery-in-
Thailand-by-uncertified-doctor.html; see also Sarah Ann Harris, Experts Blast 'Medical
Tourism' After British Woman Dies During Thai Cosmetic Procedure, EXPRESS (Oct. 24,
2014, 3:46 PM), http://www.express.co.uk/news/ukl527124/Medical-tourism-criticism-
British-death-Thailand-plastic-surgery.
11. Harris, supra note 10; see also Pearlman, supra note 10.
12. Pearlnan, supra note 10.
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despite revival attempts.13 The operating physician, who was not
properly certified for the procedure, was arrested and has been charged
in connection with her death. Yet there is no way of knowing how far a
lawsuit would proceed given the complications of international legal
action. 14 Even in a best-case scenario, a lawsuit will not bring her back
to life.
These stories indicate the range of patient experiences within this
growing global industry in which patients travel across borders for
medical treatment. In some instances, like that of Vince Ellis, medical
tourism is lauded as a panacea to the skyrocketing cost of domestic
health care in countries like the United States. 15 Medical tourism can
also allow patients to obtain treatments such as in vitro fertilization
(IVF)16 and experimental drugs that are unavailable or restricted to
certain groups in their home countries.
17
The stories of Staab and Williams, however, highlight some of the
undeniable risks of medical travel for patients, including lack of
information, unforeseen costs, medical complications, inadequate legal
redress for malpractice, and even death.'8 These troubling ramifications
have fostered a prolific discussion about possible means of regulating
the medical tourism industry.' 9  At present, however, most
commentaries discuss this burgeoning field in purely economic terms,
rather than focusing on patients' rights. 20 These approaches fail to
recognize that the globalized health care industry is fundamentally
different from other international markets. Though the expansion of
medical tourism is inextricably linked with broader globalization
13. Id.
14. Id.
15. Howard, supra note 1.
16. I. Glenn Cohen, Circumvention Tourism, 97 CORNELL L. REV. 1309, 1373 (2012)
[hereinafter Cohen, Circumvention Tourism].
17. I. Glenn Cohen, Protecting Patients with Passports: Medical Tourism and the
Patient-Protective Argument, 95 IOWA L. REV. 1467, 1477 (2010) [hereinafter Cohen,
Protecting Patients]; see also Heather T. Williams, Fighting Fire with Fire: Reforming the
Health Care System Through a Market-Based Approach to Medical Tourism, 89 N.C. L.
REV. 607, 620 (2011).
18. See infra Section II.
19. Rebecca Bennie, Medical Tourism: A Look at How Medical Outsourcing Can
Reshape Health Care, 49 TEX. INT'L L.J. 583, 591-94 (2014).
20. See, e.g., Bennie, supra note 19, at 597-600; Cohen, Protecting Patients, supra note
17 (proposing market regulation of medical tourism); Nathan Cortez, Embracing the New
Geography of Health Care: A Novel Way to Cover Those Left Out of Health Reform, 84 S.
CAL. L. REV. 859, 861 (2011) [hereinafter Cortez, New Geography]; Nathan Cortez,
Recalibrating the Legal Risks of Cross-Border Health Care, 10 YALE J. HEALTH POL'Y, L. &
ETHICS 1, 3-4 (2010) [hereinafter Cortez, Recalibrating Risks]; Williams, supra note 17, at
611.
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trends,21 it is a distinctive market because it deals not with
manufactured goods, but with living, breathing human beings seeking
life-altering and sometimes essential medical treatments.
While economic regulation of medical tourism is important,
regulation must also be informed by a human element, specifically a
focus on patients' rights. Medical tourism implicates fundamental
human experiences such as disease, suffering, vulnerability, death,
healing, and wellness. In addition, the globalization of health care has a
far-reaching impact on the meaning and scope of another human
dimension of care: the physician-patient relationship. These unique
facets of medical tourism demonstrate the need for increased emphasis
on patient-focused approaches to regulation.
This Note examines medical tourism and the impact of globalization
on health care through a patient-focused lens, drawing primarily on the
experiences of U.S. patients and U.S. laws regulating health care and
medical malpractice. The emphasis on U.S. patients is appropriate first
because medical tourism is a new and rapidly changing global industry
with limited documentation available, especially for patients traveling
from countries other than the United States.22 Moreover, because the
United States is recognized as a litigious country, especially when it
comes to medical malpractice claims, and has a highly developed system
of medical malpractice law, a U.S. focus allows for full examination of
the intersection of medical tourism and civil liability. 23 The United
States, like many other developed countries, also has various other
health-care regulation mechanisms established by governmental and
nongovernmental organizations in both the public and private sectors. 24
21. I. Glenn Cohen, Introduction to THE GLOBALIZATION OF HEALTH CARE: LEGAL AND
ETHICAL ISSUES, xiv-xxiv (. Glenn Cohen ed., 2013) [hereinafter Cohen, THE
GLOBALIZATION OF HEALTH CARE] (discussing the impact of globalization on health care).
22. See Nathan Cortez, Patients Without Borders: The Emerging Global Market for
Patients and the Evolution of Modern Health Care, 83 IND. L.J. 71, 73 (2008) [hereinafter
Cortez, Patients Without Borders] (noting the scarcity of research on medical tourism and
lack of internationally comparable data). While writing this Note, the vast majority of the
existing literature on medical tourism that I encountered focused on the United States,
with very little analysis on other countries.
23. See Amy Lynn Sorrel, Medical Liability: A World of Difference, American Medical
News, May 3, 2010, http://www.amednews.com/article/20100503/profession/305039938/41
(comparing the expense and frequency of medical malpractice litigation in the United
States to other countries); see generally J. Mark Ramseyer & Eric B. Rasmusen,
Comparative Litigation Rates, Discussion Paper No. 681, Nov. 2010, http://www.law.
harvard.edulprograms/olin-center/papers/pdfiRamseyer_681.pdf (providing a statistical
analysis of high levels of litigation in general in the United States); Kevin Drum, Why We
Sue, MOTHER JONES, Aug. 25, 2010, http://www.motherjones.com/kevin-drum/
2010/08/why-we-sue (investigating why Americans are more litigious than Europeans).
24. See Williams, supra note 17, at 654.
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Accordingly, much of the discussion, particularly of U.S. quality of care
and health care regulation, also applies to other similarly situated
developed countries around the world. For these reasons, relying on
comparison to the United States not only makes use of the relatively
limited data, but also provides a helpful basis for discussing the issues
that medical tourism raises in the broader global context.
In response to the legal and ethical challenges posed by global
medical tourism, this Note proposes the creation of an International
Constitution of Patient Rights (ICPR) as a key component of effective
regulation that will maintain the benefits of medical tourism for
patients while more fairly allocating the accompanying risks. Part I
introduces the concept of medical tourism and examines the complex
dynamics that have shaped the emergence of this global trend. Part If
discusses the dark side of medical tourism, identifying risks to patients
as well as associated legal and ethical issues. Part III then examines
existing and proposed options for regulating medical tourism. Part IV
argues that the creation and multilateral adoption of an International
Constitution of Patient Rights will protect patients' interests as well as
those of other participants in medical tourism and so play a pivotal
regulatory role. Part V then proceeds to outline preliminary ICPR
provisions. Finally, Part VI of this Note identifies issues that must be
resolved in the process of drafting the ICPR and responds to potential
criticisms.
I. THE EMERGENCE AND BENEFITS OF MEDICAL TOURISM
A. Emergence of the Medical Tourism Industry
In medical tourism, patients travel from a home country to a foreign
destination to receive medical treatment.25 While this term evokes
modern images of patients going on long-distance flights halfway
around the globe for surgeries or experimental medical treatments, the
basic idea of traveling for health care is certainly not novel. Ancient
Greeks and Romans traveled across borders seeking the health benefits
of mineral spas and hot springs along the Mediterranean coast.26 In
more recent history, wealthy individuals from foreign countries have
traveled to the United States for decades to receive treatment from
premiere health care providers like the Cleveland Clinic and Mayo
Clinic. 27 In the present day, however, medical tourism has taken on a
25. Cohen, Protecting Patients, supra note 17, at 1471.
26. See id.
27. See Bennie, supra note 19, at 585 (discussing how the United States has been a
sought after medical tourism destination because U.S. hospitals offer the most cutting
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new meaning and has expanded to become a global industry. 28 It
generates an estimated $50 billion to $60 billion annually, with
anticipated growth to $100 billion in the next decade. 29 While the exact
extent of medical tourism is difficult to calculate, the U.S. industry
group Patients Beyond Borders estimates approximately eleven million
patients travel across borders for medical treatment annually. 30
Trends in patient travel patterns have shifted dramatically in
recent years. In the past, medical tourists were generally wealthy
individuals from less-developed countries seeking care in more-
developed countries. 31 Today, however, more and more patients from the
United States and other developed countries travel to less-developed
countries for treatment. 32 While estimates vary, the Deloitte consulting
group's report on medical tourism calculated that 750,000 patients
travelled from the United States to receive medical treatment in foreign
countries in 2007, with forecasted growth of 35 percent. 33 Meanwhile,
more recent assessments and studies defining medical tourism more
broadly propose estimates of up to one million U.S. patients per year. 34
edge medical treatments and technologies); Cortez, Patients Without Borders, supra note
22, at 76.
28. Bennie, supra note 19, at 584-85.
29. Id.; see Thomas Johnsrud, Medical Thavel Can Save Money During Bad Economy,
but at What Cost?, J. COMPENSATION & BENEFITS, Mar.-Apr. 2009, at 1; see also Aya
Batrawy, Dubai Cuts Profile as Mideast Plastic Surgery Hub, YAHOO NEWS (Oct 23, 2014,
3:03 AM), http://news.yahoo.comdubai-cuts-profile-mideast-plastic-surgery-hub-070333252.
html,ylt;=AwrBTzcUTRVg7cAq. IXNyoA;_ylu=X3oDMTEyaWFrOHRIBGNvbG8DYmYxBHBv
cwMxBHZOaWQDQjA5ODdfMQRzZWMDc3I-.
30. Medical Tourism Statistics & Facts, PATIENTS BEYOND BORDERS, http://www.
patientsbeyondborders.com/medical-tourism-statistics-facts (last updated July 6, 2014).
31. See Cortez, Patients Without Borders, supra note 27, at 76.
32. Medical tourists today mostly choose from a handful of major destination countries.
Not all countries seek to attract foreign patients, and patients generally do not receive all
medical treatment abroad if the need is urgent or if treatment can be obtained at a
reasonable cost domestically. See id. at 91-92. Some of the main destination countries
include India, Malaysia, Singapore, South Korea, Taiwan, Thailand, Turkey, Jordan,
Israel, Costa Rica, Chile, and Cuba. See id. at 89-95. Several factors contribute to whether
a country becomes a major destination for medical tourism, including large investments in
health care infrastructure, commitment to quality assurance, transparency, established
reputation, availability of well-trained medical practitioners and particular treatments,
and affordability. Medical Tourism Statistics & Facts, supra note 27.
33. PAUL H. KECKLEY & HOWARD R. UNDERWOOD, DELOITTE CTR. FOR HEALTH
SOLUTIONS, MEDICAL TOURISM: UPDATE AND IMPLICATIONS 3 (2009) [hereinafter Deloitte
Report], available at http://www.medretreat.com/templates[UserFiles/Documents/
Deloitte%20Report%2020091023.pdf; see also Cortez, New Geography, supra note 20, at
878; Medical Tourism, CTRS. FOR DISEASE CONTROL AND PREVENTION, http://www.cdc.
gov/features/medicaltourism (last updated Feb. 23, 2015).
34. Williams, supra note 17, at 609 n.10 ("Due to the unexpected economic downturn
and a resulting decrease in Americans' spending on even necessary medical care, the
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Though the lack of regulation makes data collection difficult, available
estimates nevertheless indicate that medical tourism is a sizeable and
rapidly growing industry.35
Broader trends in health care globalization have fueled medical
tourism's explosive growth. Globalization in the medical tourism context
is perhaps best understood through the two core ideas of
deterritorialization and social interconnectedness.36  In
deterritorialization, important social practices that were once local have
become increasingly separate from participants' physical location.3
7
Deterritorialization has caused the globalization of a whole range of
traditionally local health care services once bounded by economics,
geopolitical borders, and cultural barriers.38 In turn, the markets for
health care professionals, pharmaceuticals, and other medical
technologies that were once under the control of domestic governments
have become increasingly transnational and privatized, potentially
evading regulation.3 9 Social interconnectedness characterizes the way
that geographically distant events and circumstances shape local and
regional activities, economic behaviors, decision-making, and other
social practices. 40 In the medical context, social interconnectedness has
allowed international health care providers to compete for patient-
customers who formerly obtained treatment locally.4 1 Technological
interconnectedness, especially via the Internet, has also increased
knowledge sharing, fostering the standardization of medical practices
while increasing patient agency and access to information. 42
Deloitte Center for Health Solutions recently revised its estimate to 1.6 million
individuals in 2012.").
35. Cortez, Patients Without Borders, supra note 27, at 76.
36. This use of the term globalization coincides with the predominant approaches in
existing literature relating to medical tourism. See Cohen, THE GLOBALIZATION OF
HEALTH CARE, supra note 21, xxii (citing William Scheuerman, Globalization, THE
STANFORD ENCYCLOPEDIA OF PHILOSOPHY (Edward N. Zalta ed., 2010), available at
http://plato.stanford.edu/archives/sum20lO/entries/globalization/.
37. Id.
38. Cortez, Patients Without Borders, supra note 27, at 76.
39. See Cohen, THE GLOBALIZATION OF HEALTH CARE, supra note 21, at xiii-xviii;
Cortez, Patients Without Borders, supra note 27, at 88.
40. Cohen, THE GLOBALIZATION OF HEALTH CARE, supra note 21, at xxii-xxiv.
41. Id.; Cohen, Protecting Patients, supra note 17, at 1471 ("lIt has become
increasingly apparent that healthcare has ceased to be a good supplied and consumed
purely locally and has instead become a truly globalized good, as a number of journalists,
physicians, and policy makers have recognized.").
42. See Cohen, Protecting Patients, supra note 17, at 1471; see also Cortez, Patients
Without Borders, supra note 27, at 88 (discussing the globalization of related industries in
health care); Michael Klaus, Outsourcing Vital Operations: What If U.S. Health Care Costs
Drive Patients Overseas for Surgery?, 9 QUINNIPIAC HEALTH L.J. 219, 219-20 (2006).
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B. Benefits for Medical Tourism Patients
Medical tourism can provide a variety of benefits to patients
including enhanced patient agency, financial cost-savings, and
increased treatment access. Patient agency refers to a patient's ability
to exercise control over medical treatment and who will provide it.43
Some patients exercise agency and express autonomy through control
over medical decision-making, 44 while others choose to delegate
decision-making to physicians. Medical tourism arguably enhances
patient agency because it allows patients to find practitioners willing to
provide care in a manner consistent with patients' values, medical
needs, and financial limitations.45 Medical tourism patients may be
prompted to exercise agency for two broad reasons. 46 First, patients may
obtain treatment abroad that they cannot afford at home.47 Second,
patients may seek treatments they cannot access at home.48
In cost-driven medical tourism, uninsured or underinsured patients
obtain treatment abroad to save money. Most cost-driven medical
tourists are from Western countries and are unwilling or unable to pay
for expensive domestic health care. As globalization has accelerated the
diffusion of medical knowledge and technology, these patients turn to
providers in developing countries that offer the same treatments at
significantly lower prices. Deloitte's 2009 report on medical tourism
asserts that U.S. patients obtaining treatment abroad can save up to 70
percent even after including travel expenses. 49 Comparing individual
procedures further demonstrates the significant cost discrepancies
driving medical tourism. 50 For example, Staab's life-saving mitral heart
valve replacement surgery would have cost $200,000 if performed in the
43. Williams, supra note 17, at 618-19; see also Cortez, Patients without Borders, supra
note 27, at 111-13 (discussing medical tourism and "enhanced patient autonomy"); Note,
Restructuring Informed Consent: Legal Therapy for the Doctor-Patient Relationship, 79
YALE L.J. 1533, 1554 (1970) (discussing how patient agency is rooted in fundamental
rights to bodily integrity and self-determination).
44. Williams, supra note 17, at 618.
45. Id. at 619.
46. Cortez, Patients without Borders, supra note 27, at 77.
47. Id.
48. Id.; see also Cohen, Circumvention Tourism, supra note 16, at 1311-13; Howard D.
Bye, Shopping Abroad for Medical Care: The Next Step in Controlling the Escalating
Health Care Costs of American Group Health Plans?, HEALTH LAw, Apr. 2007, at 30.
49. Deloitte Report, supra note 30, at 2.
50. Bennie, supra note 19, at 587-88; see also Stephen Samlan, Medical Tourism:
Opportunity to Control Escalating Health Care Costs in the United States?, ANNALS
HEALTH L. ADVANCE DIRECTWVE, Fall 2010, at 136, 137-38.
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United States. 51 Traveling to India for the surgery reduced the total
procedure cost (including travel expenses for him and a companion) to
only $6,700.52 Nonsurgical procedures and treatments also cost
substantially less. For example, a comprehensive fitness exam will cost
at least $4,000 in the United States, but only $125 in India.53
Access-driven medical tourists seek many treatments that are either
illegal or subject to restricted access in their home countries. 54
Restrictive domestic laws may provide incentives for seeking treatment
in another country with more permissive laws. 55  Cohen uses
"circumvention tourism" to describe the practice where "a patient has
traveled to the destination country to circumvent domestic prohibitions
on accessing services." 56 These restrictions can exist for several reasons,
including home country laws restricting treatment access. 57 Examples of
popular circumvention tourism treatments include IVF, abortion,58
surrogacy,59 assisted suicide or "death tourism," 60 and cultural practices
like female genital cutting.61
Other treatments are unavailable because they lack regulatory
approval. Patients from the United States cannot access drugs and
other medical technologies until the Food and Drug Administration
(FDA) has conducted a lengthy and stringent approval process. Patients
who urgently need treatment or are unwilling to wait may travel to
foreign countries where the treatment is already available. In addition,
even when no legal or regulatory barriers restrict access, treatments can
be inaccessible if physicians, hospitals, or insurers refuse to provide or
51. Cortez, New Geography, supra note 20, at 877; Senate Hearing, supra note 5, at 26
(statement of Bonnie Blackley, Corporate Benefits Director, Blue Ridge Paper Products).
52. Senate Hearing, supra note 5, at 9 (written statement of Maggi Ann Grace).
53. Samlan, supra note 47, at 138 (discussing disparities in health care costs between
the home countries of medical tourists and destination countries).
54. Cortez, Patients Without Borders, supra note 27, at 77.
55. Id.
56. Cohen, Circumvention Tourism, supra note 16, at 1312 (providing a more in-depth
discussion of circumvention tourism and proposing legal solutions for dealing with the
issues it raises).
57. Id.
58. For example, laws prohibiting abortion in Ireland give rise to circumvention
tourism by women seeking abortions in the United Kingdom. See Cortez, Patients Without
Borders, supra note 27, at 76.
59. Cohen, Circumvention Tourism, supra note 16, at 1317.
60. Id. at 1326; see also Cecilia Rodriguez, Legal Euthanasia for Children in Belgium:
Will It Trigger Death Tourism?, FORBES (Mar. 6, 2014, 5:17 PM), http://www.forbes.
com/sites/ceciliarodriguez/2014/03/06/2378/ (discussing the impact of permissive
euthanasia laws in Belgium on attracting medical tourists).
61. Cohen, Circumvention Tourism, supra note 16, at 1317.
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pay for it.62 Moreover, providers in some less developed countries may
lack particular medical technology or expertise, forcing patients to seek
treatment abroad. 63 Finally, patients in countries with socialized health
care may use medical tourism to bypass waiting lists and obtain
treatment more quickly.64
II. THE DARK SIDE OF MEDICAL TOURISM
Although patients use medical tourism to obtain access and cost-
savings, they also invariably face accompanying risks. These risks raise
significant concerns, demonstrating the need to regulate medical
tourism and protect patients' rights.
A. Inherent Risks and Quality-of-Care Concerns
Medical tourism carries certain risks simply because it involves
international travel. Medical tourists risk additional travel expenses,
miscommunication due to language and cultural barriers, exposure to
foreign diseases, as well as aggravated medical conditions and
unanticipated travel delays should medical complications arise.6 5 In
addition, critics have pointed out that treatment prescreening and
follow-up care may be insufficient due to the long-distance physician-
patient relationship. 66 While physicians in destination countries can
view patient records, they cannot physically examine patients until
shortly before treatment begins.67 Furthermore, once patients have
returned home, the treating physicians no longer provide care, and
patients may have difficulty obtaining and paying for follow-up care if
complications arise. 68
62. Cortez, Patients Without Borders, supra note 27, at 78. For example, in Mississippi,
there is only one operating abortion clinic even though federal law bans the complete
prohibition of abortion. Id. A more common manifestation of restricted access occurs when
insurers refuse to cover particular treatments for a variety of reasons and that decision
incentives patients to seek health care abroad. Id.
63. Id. at 79.
64. Id.
65. Bennie, supra note 19, at 591.
66. Cortez, Patients Without Borders, supra note 27, at 103-04; Klaus, supra note 38,
at 227.
67. Cortez, Patients Without Borders, supra note 27, at 103.
68. Id. at 104; Klaus, supra note 39, at 227.
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Health care quality is another major concern for patients that has
been dubbed the "great unknown" of medical tourism. 69 Health care
quality is not uniform within and may vary significantly across different
destination countries. 70 Furthermore, the absence of centralized medical
tourism regulation and data collection makes it extremely difficult to
measure quality. 71 Current methods, such as measuring quality through
mortality rates, can be misleading and oversimplify complex treatment
contexts that depend on patient characteristics, treatment type, and
countless other circumstantial factors.7 2 Although mortality statistics
can be misleading, other factors like patient satisfaction and level of
improvement are difficult to measure accurately. 73 This lack of
comprehensive data and of appropriate metrics contributes to ignorance
about health care quality in medical tourism.
7 4
On the one hand, medical tourism proponents point to evidence
suggesting patients can obtain treatment abroad that is at least on par
with what they would have received at home, for example, in the United
States, where medical care is highly regulated. 75 The staffs at many
destination facilities include physicians and other health care
professionals who have been certified in and practiced in the United
States prior to starting their practices overseas.7 6 For example, over 200
U.S. Board-certified physicians staff the popular destination of
Bumrungrad Hospital in Bangkok, Thailand.77 Testimonials suggest
69. Cortez, Patients Without Borders, supra note 27, at 107; see also Cohen, Protecting
Patients, supra note 17, at 1489; Cortez, Recalibrating Risks, supra note 20, at 3;
Williams, supra note 17, at 627-28.
70. Cortez, Patients Without Borders, supra note 27, at 102; see also Williams, supra
note 17, at 632.
71. Cortez, Patients without Borders, supra note 27, at 107 n.82 ("Iveasuring the
'quality' of health care is inherently difficult. In the United States, professional licensure,
board certification, and hospital accreditation ensure that our health care professionals
and facilities meet some minimum quality standards. However, these systems are not
necessarily designed to assure that high quality health care is actually being provided.")
(citing Timothy S. Jost, The Necessary and Proper Role of Regulation to Assure the Quality
of Health Care, 25 HOUS. L. REV. 525 (1988); Timothy S. Jost, Oversight of the Quality of
Medical Care: Regulation, Management, or the Market?, 37 ARiZ. L. REV. 825, 858-66
(1995)); see also Williams, supra note 17, at 628-29.
72. See Cortez, Patients Without Borders, supra note 27, at 103; Cohen, Protecting
Patients, supra note 17, at 1491-92.
73. Cortez, Patients Without Borders, supra note 27, at 103.
74. See id. at 103.
75. See Cohen, Protecting Patients, supra note 17, at 1492; Klaus, supra note 39, at
225.
76. See Klaus, supra note 39, at 225-26.
77. Id. at 226; see also Fred de Sam Lazaro, Travelers Head to Thailand for Inexpensive
Medical Procedures, PBS NEwsHOUR (Feb. 21, 2005, 12:00 AM), http://www.pbs.org/
newshour/bb/health/jan-june05/thailand_2-21.html.
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that some have even found the health care in destination countries to be
superior to that of their home countries.78 Furthermore, the Joint
Commission International (JCI) (formerly the Joint Commission on
Accreditation of Healthcare Organizations), a branch of the U.S. Joint
Commission that controls domestic hospital regulation, has established
an international accreditation process that foreign hospitals may apply
for and receive if they meet certain standards. 79
While high-quality medical tourism destinations may meet domestic
health care standards, the lack of consistent and enforceable regulation
still creates unacceptably high risks.80 For example, while JCI
accreditation of overseas hospitals supposedly requires compliance with
quality standards, destination facilities are not required to obtain
accreditation. 81 Furthermore, skeptics point out that "JCI may have a
design that pushes it to be pro-accreditation" since it "has its own
incentives that come into play in its role as accreditor and may give us
pause: it has a very high rate of accreditation and low rate of revocation,
and its revenues depend on the number of hospitals it accredits."8 2
Media coverage of medical tourism horror stories demonstrates
these risks. Many cases involve botched cosmetic surgeries and
disfigurement, while others involve unlicensed practitioners or
ineffective sterilizations resulting in fatal hepatitis infections and blood
clots.8 3 For example, the death of twenty-four-year-old Joy Williams
from anesthesia in Thailand illustrates just how grave these risks can
be.8 4 Furthermore, patients who return home with complications from
botched treatments must find and pay for follow-up care which may be
78. See Cohen, Protecting Patients, supra note 17, at 1492; see also Williams, supra
note 17, at 633-35.
79. Cortez, Patients Without Borders, supra note 27, at 83.
80. See generally Cohen, Protecting Patients, supra note 17, at 1493 (explaining the
difficulty patients experience when assessing quality of medical care). But see Williams,
supra note 17, at 631 C'Despite the absence of adequate evidentiary measures to assess
quality . . . several quality assurance measures indicate high quality among common
medical tourism facilities.").
81. See Bennie, supra note 19, at 589 (stating that patients may avoid low-quality
health care by going to accredited rather than unaccredited hospitals); Cortez, New
Geography, supra note 20, at 897 ("[S]tates [in cross-border insurance programs] can
require that insurers utilize only foreign hospitals that are accredited.").
82. I. GLENN COHEN, PATIENTS WITH PASSPORTS: MEDICAL TouRIsM. LAW AND ETHICS
60 (2015).
83. Keith Pollard, Cosmetic Surgery Abroad Under the Spotlight, INT'L MED. TRAVEL J.
(Mar. 20, 2014) http://www.imtj.comfblog/cosmetic-surgery-abroad-under-spotlight//; see
also Kristen Boyle, A Permanent Vacation: Evaluating Medical Tourism's Place in the
United States Healthcare System, HEALTH LAW., June 2008, at 42, 46 (discussing
"disfigurement and fatal infections linked to ... unaccredited hospitals and unlicensed
surgeons").
84. See Pearlman, supra note 10.
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too expensive and provided by domestic physicians who are wary of
assuming liability.85 Despite these legitimate concerns, however,
medical tourism proponents point out that proactive patients can avoid
many risks by thoroughly researching the destination country and only
patronizing accredited facilities. 86
B. Inadequate Legal Remedies for Medical Malpractice
An even more disconcerting risk is the lack of a legal remedy for
foreign medical malpractice. 87 The challenges faced by some U.S.
patients when seeking legal remedies in destination countries are
illustrative. While U.S. patients have recourse to well-developed
medical malpractice laws, many destination countries do not afford
patients anywhere near this level of protection.8 8 For U.S. patients who
wish to sue foreign physicians for medical malpractice in domestic
courts, it is difficult to establish jurisdiction.8 9 Even if the plaintiff can
show personal jurisdiction over the foreign defendant, the court will
likely grant a defendant's motion to dismiss for lack of a convenient
forum (forum non conveniens) if the defendant can show that an
alternative forum exists in the destination country. 90 The standard for
what constitutes a viable alternative forum is quite permissive, and the
fact that damage recovery under another country's law is less favorable
than in the United States may carry little weight in a court's
assessment of the alternative forum's adequacy. 9 1 In turn, a plaintiff-
patient may have to resort to suing in the destination country even if
the remedies are not comparable as long as some minimal remedy is
available. 92 In effect, these patients may be left without a viable remedy
in a suit directly against foreign providers.
93
85. Klaus, supra note 39, at 226-27.
86. See Bennie, supra note 19, at 589; Williams, supra note 17, at 635 (explaining
medical tourists may select providers who meet their preferred criteria by reviewing
physician credentials online).
87. See generally Bennie, supra note 19, at 592-93 (addressing the lack of legal remedy
both domestically and abroad for foreign medical malpractice).
88. Id.
89. See Howze, supra note 8, at 1031-32.
90. Id.
91. See id. at 1034.
92. See id.
93. Id. at 1038 (discussing the major destination country of India as an example,
Howze points out that "[b]ecause of the difficulties associated with adjudication of a
medical negligence claim in India and the minimal possible recovery, and because of the
unlikelihood of redress in a U.S. court, the potential remedy provided by a direct suit
against Indian providers for medical negligence is severely restricted"). Alternatively,
patients may try to sue brokers and other middlemen that are usually based in the United
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Moreover, medical tourists may be unaware that they are
essentially forfeiting legal remedies. 94 As Cortez points out, "[tihere is
reason to suspect that [patients travelling abroad] do not fully digest
just how few legal remedies remain or what options they have if
something goes awry .... The patients diligent enough to investigate
these legal disparities will not find much helpful information."95 For
example, in many Asian destination countries, patients are asked to
sign waivers barring malpractice suits.96 While U.S. courts have held
such waivers to be void as against public policy, recognizing health care
services as relevant to the public interest, 97 many foreign jurisdictions
are likely to enforce malpractice waivers. 98
Furthermore, even if patients can sue in the destination country,
they rarely prevail because foreign cultural and legal systems
oftentimes strongly favor physicians. 99 Even if a patient successfully
litigates a foreign medical malpractice case, damages in destination
countries are usually only a fraction of comparable awards in the United
States.100 Finally, enforcing judgments and actually collecting damages
from uncooperative defendants may prove practically impossible. 101
Along these lines, while foreign hospitals competing for patients
certainly have incentives not to injure medical tourism patients, the
absence of sufficient legal remedies coupled with medical tourists'
ignorance that they are foregoing legal remedies are significant
concerns.
States and therefore under the jurisdiction of domestic courts. Williams, supra note 17, at
644. But many patients do not use brokers, and so this remedy is limited to those who do.
Id. Moreover, plaintiffs are unlikely to recover damages from brokers because it is difficult
to establish actual or proximate causation or vicarious liability based on the relationship
between the broker and health care provider. Id.
94. Cortez, Recalibrating Risks, supra note 20, at 3.
95. Id. at 3-4.
96. See id. at 2-3.
97. See, e.g., Tunkl v. Regents of the Univ. of Cal., 383 P.2d 441, 442 (Cal. 1963). For
additional discussion of the Thnkl case and the U.S. prohibition of medical waivers, see
Cohen, Protecting Patients, supra note 17, at 1528-29.
98. See Williams, supra note 17, at 642.
99. See, e.g., Howze, supra note 8, at 1034-35 (considering that, for example, in India,
95 percent of medical malpractice cases are dismissed, and parties in the 5 percent that
proceed must wait a long time to be heard).
100. See Cortez, Recalibrating Risks, supra note 20, at 4 ("For example, the mean and
median recoveries by malpractice victims in the United States ($311,000 and $175,000,
respectively) dwarf the average recoveries in Thailand ($2500) and Mexico ($4800) .... If
patients travel overseas for less expensive health care (particularly if they are encouraged
to do so), they should understand precisely what remedies they are sacrificing.").
101. See Williams, supra note 17, at 645.
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III. EXISTING AND PROPOSED REGULATION OF MEDICAL TOURISM
At present, the medical tourism industry is largely unregulated. 02
Though several regulatory frameworks exist, and others have been
proposed, they vary in effectiveness and are inadequate to deal with the
unique challenges of medical tourism. The shortcomings of existing
frameworks highlight areas in which an International Constitution of
Patient Rights (ICPR) can help to more effectively regulate medical
tourism.
A. Unilateral Domestic Regulation
Established health care regulatory frameworks are almost
exclusively domestic and likely do not apply globally, leaving medical
tourism to market regulation.10 3 In the United States, for example,
domestic health care regulation centers on three core methods10 4: the
government may create laws governing health care providers, it may
recognize patient causes of action, and it may exercise its power as a
large health care purchaser through programs like Medicare and
Medicaid to create contractual obligations, thereby imposing
requirements on health care providers. 10 5
These methods of regulating health care are not readily transferable
to medical tourism. 10 6 U.S. laws and jurisdiction generally do not extend
extraterritorially. Even if jurisdiction is established, enforcing laws
regarding licensing requirements and malpractice against foreign
physicians is likely impracticable. 10 7 Moreover, U.S. federal and state
governments have shied away from acting as a large foreign health care
purchaser to exercise regulatory influence.108
102. Deloitte Report, supra note 30, at 13.
103. See Williams, supra note 17, at 653-54. Existing literature provides comprehensive
discussion of existing health care regulation. See Cohen, Protecting Patients, supra note
17, at 1489 (discussing domestic regulation of health care including "the accreditation,
certification, and professional self-regulation of physicians and other healthcare providers,
the medical-malpractice system, reporting of malpractice suits . . . the licensure and
accreditation of hospitals, medical staff bylaws, hospital privileges regulation, conflict of
interest regulation, and anti-kickback statutes.").
104. See Williams, supra note 17, at 654.
105. See id.
106. See id.
107. See id.
108. See id. at 655-56. (indicating that in addition to the overwhelming domestic
opposition to "outsourcing health care," no substantial quality of care or accreditation
requirements have been included in the unsuccessful proposals of Colorado and West
Virginia, the only states that have considered becoming medical tourism purchasers).
INDIANA JOURNAL OF GLOBAL LEGAL STUDIES 23:2
Other forms of unilateral regulation include efforts to regulate
patient travel, brokers, and health insurers along with increasing
governmental oversight of medical tourism. 109 In proposed regulations,
the federal government would build on domestic regulation by
expanding consumer protection measures and licensing requirements. 110
Yet such proposals have significant weaknesses. For example, these
domestic regulations would only apply to U.S. citizens who travel to
obtain treatments legally approved in both the United States and
destination countries."' In turn, these regulations could leave both non-
U.S. citizens and those patients who obtain treatments only approved in
the destination country unprotected.
B. Multilateral Regulation
The United States could also influence the international medical
tourism market through promulgating multilateral trade agreements
that would ensure service quality.112 In this approach, countries could
mutually agree to quality standards for medical care, protecting foreign
nationals traveling either to the United States or to other nations for
treatment. 113 Critics argue that a trade agreement would be ineffective
because agreements that restrict rather than enhance trade are usually
not well received." 4 Moreover, it may be difficult for countries to agree
on applicable standards. 115
To avoid this issue, scholars have proposed various methods of
regulating medical tourism by relying on existing agreements such as
the General Agreement on Trade in Services (GATS).116 Regulating
medical tourism through GATS may make sense because it is
"[a]rguably, the most significant piece of international law with respect
to cross-border mobility for tourists."117 Yet, relying on GATS in the
109. For further discussion, see Cortez, Patients Without Borders, supra note 27, at 113.
110. See id.
111. See Cohen, Circumvention Tourism, supra note 16, at 1331-35 (discussing
limitations on jurisdiction and the international legal authority relating to medical
tourism).
112. See Williams, supra note 17, at 657.
113. See id.
114. See id. at 658.
115. See id. (discussing how the United States is unlikely to "persuade other nations to
restrict their domestic health care market" in order to meet U.S. standards).
116. Cf. id. (assessing GATS as a proposed means of regulating medical tourism and
identifying the pitfalls of arguments in favor of this approach).
117. C. Michael Hall, The Contested Futures and Spaces of Medical Tourism, in
MEDICAL TOURISM: THE ETHIcs, REGULATION, AND MARKETING OF HEALTH MOBILITY 203,
205 (C. Michael Hall ed., 2013) [hereinafter Hall, Contested Futures].
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health care sector could actually make it more difficult for countries like
the United States to require higher domestic quality standards.118 For
example, if GATS were expanded to include medical tourism, strict
requirements in the United States like rigorous licensing processes for
physicians and hospitals could be considered impermissible barriers to
trade that would have to be removed.1 1 9 In addition, proposed regulation
of medical tourism through GATS has focused on the "movement of
natural persons [as] one of the modes of supply for services," treating
patients purely as vacation tourists traveling for consumption abroad. 120
This approach fails to address the unique challenges of medical tourism
and does not recognize the importance of protecting vulnerable patients
who are oftentimes compelled by unavoidable circumstances to travel
for medically necessary treatment.
C. Market Self-Regulation Through Private Sector Accreditation
Though various government regulations could be implemented, the
market currently remains largely internally regulated by private
industry and principles of free-market competition. 121 Since the Deloitte
report was published in 2009, governmental oversight of medical
tourism is unchanged 122 but significant private sector regulation has
developed. 123 While this self-regulation has influenced medical tourism,
it is insufficient to protect patients.
The most significant form of private sector regulation is
accreditation of overseas health care facilities. 124 Many health care
providers in destination countries seek Joint Commission International
(JCI) accreditation. 125 As discussed above, the JCI is the international
branch of the Joint Commission, which controls accreditation of U.S.
hospitals. 126 Though the JCI accreditation process is separate from the
Joint Commission, the JCI uses similar standards when determining
118. See Williams, supra note 17, at 658.
119. See id.
120. Hall, Contested Futures, supra note 117.
121. See Deloitte Report, supra note 30, at 4 ('[T]hus far the medical tourism industry as
a whole has remained mostly unstructured, with no meaningful legislation to govern the
practices of participating organizations.").
122. See generally Bennie, supra note 19 (analyzing medical tourism from the more
recent 2014 perspective).
123. See Cortez, Patients Without Borders, supra note 27, at 78.
124. See Williams, supra note 17, at 665.
125. See id. It should also be noted that, while the JCI is the most widely recognized
international accreditation body, it is not the only one and organizations based in the
United Kingdom also play a role in accreditations and private sector quality regulation.
126. See id. at 666.
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whether to accredit a medical tourist destination facility.' 27 Due to the
JCI's close relationships with the U.S. Joint Commission and trade
organizations like the American Medical Association, many in the
international community see JCI accreditation as quality assurance. 128
In addition, the JCI goes beyond accreditation by establishing quality
standards and educating health care providers about best practices.1 29
While obtaining JCI accreditation is not mandatory, it has arguably
become a de facto requirement for overseas health care facilities wishing
to be competitive in attracting foreign patients. 130 Because patients can
access online information to research options,' 3 ' JCI accreditation
purportedly indicates to patients whether a facility meets minimum
requirements and offers health care comparable in quality to U.S.
hospitals. 132
Nevertheless, skeptics of JCI accreditation assert that it is
insufficient to protect patients. One criticism is that the JCI criteria for
international accreditations are more lax and less enforceable than the
strict standards for domestic certification. In addition, the JCI is subject
to very little government oversight. 133 High accreditation rates and low
revocation incidences, coupled with the fact that the organization relies
on accreditation fees for revenue, raise concerns that the JCI cannot
fulfill the role of a patient-centered guardian of care quality. 3 4
Several commentators have argued for extending private sector
medical tourism regulation through government-mandated
transparency 135 or other "information forcing intervention[s]. ' ' 136 While
increased information access is a step in the right direction, these
proposals leave significant gaps and do not go far enough to protect
patients. For example, transparency proposals focus either primarily or
exclusively on treatments or procedures that are legal in both countries,
127. See Cohen, Protecting Patients, supra note 17, at 1485 (discussing the JCI
accreditation process, in which health care organizations are evaluated at the time of
accreditation and every three years thereafter). If an organization fails to meet all of the
standards, it is given a period to correct the issue and must provide written proof of
compliance to the JCI or go through a follow-up evaluation. The JCI has now accredited
over 250 organizations outside the United States. See id.
128. See Williams, supra note 17, at 665.
129. See Williams, supra note 17, at 632, 665; see also Facts About the Joint
Commission, JOINT COMM'N (July 29, 2015), http://www.jointcommission.org/facts_
aboutLthejoint-commission/.
130. Cf. Williams, supra note 17, at 633.
131. Cortez, Patients Without Borders, supra note 27, at 85.
132. See Williams, supra note 17, at 633.
133. See Cortez, Patients Without Borders, supra note 27, at 126.
134. See id.
135. See Williams, supra note 17, at 669-70.
136. See Cohen, Protecting Patients, supra note 17, at 1506-11.
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failing to account for circumvention tourism patients seeking
treatments unavailable at home.
137
In addition, simply providing patients with information does not
address the problem of malpractice recovery in medical tourism.
13 8
While patients could be more informed about how medical tourism
limits their ability to seek legal redress, information alone does not
make it easier for current malpractice plaintiffs to recover damages, and
even informed patients who choose the ostensibly safest hospitals may
be victims of negligence. 139 Moreover, efforts to educate patients about
restricted international legal remedies may not help those patients who
are financially compelled to seek health care abroad, especially if the
foreign country is competing with the prices or services of the patient's
home country. 140 Without any additional protections, medical tourists as
both consumers and vulnerable patients remain unfairly subject to
malpractice risks. 4 1
IV. THE INTERNATIONAL CONSTITUTION OF PATIENT RIGHTS:
JUSTIFICATION AND BENEFITS
Thus far, this Note has discussed the emergence, benefits, and
potential problems of the growing medical tourism industry. An
assessment of existing and proposed regulatory approaches illustrates
that these means are insufficient to ensure quality care standards and
protect patients' rights to legal redress. Here, I argue that the creation
and multilateral adoption of an International Constitution of Patient
Rights (ICPR) is a key first step to protecting the interests of patients,
health care providers, and other parties so as to maintain the benefits of
medical tourism while minimizing and more fairly allocating its risks.
First, I build on the preceding discussion to demonstrate why the ICPR
is an appropriate means of addressing the challenges medical tourism
presents. Next, I provide a preliminary overview of the ICPR,
suggesting key provisions that should be included. Finally, I identify
areas for further consideration and respond to possible criticisms.
137. See generally id. at 1477 (focusing a proposal primarily on treatments legal in both
countries).
138. See Cortez, Recalibrating Risks, supra note 20, at 77.
139. See id.
140. Cf. id. (explaining that because many foreign countries are participating in a "race
to the bottom" to provide medical services that are lower in cost and often banned in the
patient's home country, patients of lesser means will feel compelled to take advantage of
these prices and services, despite being aware of the risks).
141. See id.
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A. Insufficiency of Existing Regulation and Gaps in International Law
Creating an ICPR is both appropriate and beneficial for several
reasons. The ICPR would provide a foundation for multilateral
governmental action to protect patients by identifying universally
recognized patient rights. These agreed-on rights could lay the
groundwork for more comprehensive, coordinated government action to
regulate health care across borders. Unlike existing regulations focusing
primarily on parties' economic interests and portraying patients solely
as consumers, the ICPR also emphasizes patients' interests from a
human rights perspective. In turn, the ICPR would offer a more holistic
approach by taking into account economic benefits, patients' autonomy,
and their moral rights to health care and legal redress. 142
The ICPR would also address inadequacies in existing international
law governing patients' human rights. Existing international law
focusing on human rights does little to address the specific issues of
patients' rights. 143 For example, the Universal Declaration of Human
Rights (UDHR), adopted by the United Nations (U.N.) in 1948, is
perhaps the most influential international document relating to
individual human rights, and has acquired the status of customary
international law. 44 The UDHR contains provisions discussing human
rights to health and well-being generally, but does not specifically
address patients' rights and certainly does not anticipate medical
tourism's unique challenges. 145
142. For further discussion of the role of international law relating to the moral right to
health care, see Pavlos Eleftheriadis, Global Rights and the Sanctity of Life, in THE
GLOBALIZATION OF HEALTH CARE, supra note 21, at 421.
143. See id. (discussing the absence of clear rights and duties relating to health care in
existing international law documents); see also Universal Declaration of Human Rights,
G.A. Res. 217 (III) A, U.N. Doc. A/RES/217(III) (Dec. 10, 1948).
144. See Office of the High Comm'r of Human Rights, Digital Record of the UDHR,
UNITED NATIONS HUMAN RIGHTS (Feb. 2009), http://www.ohchr.org/EN/
NEWSEVENTSIPages/DigitalrecordoftheUDHR.aspx (asserting that the UDHR is "widely
regarded as forming part of customary international law") [hereinafter Digital Record of
the UDHR]; see also Hurst Hannum, The Status of the Universal Declaration of Human
Rights in National and International Law, 25 GA. J. INT'L & COMP. L. 287, 289 (1996).
145. See Universal Declaration of Human Rights, supra note 144; see also I. Byrne et al.,
Human Rights in Patient Care: Ukraine, in A PRACTITIONER GUIDE 24 (Ser. No. UDC
342.951:351.778(477) 2012), available at http://www.opensocietyfoundations.org/sites/
default/files/Practitioner-Guide-Ukraine-English-20130516.pdf. ("Key provisions include:
Article 3 (right to life), Article 5 (prohibition on torture and cruel, inhuman, or degrading
treatment), Article 7 (protection against discrimination), Article 12 (right to privacy),
Article 19 (right to seek, receive, and impart information), Article 25 (right to medical
care).").
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Building on the foundation of the UDHR, the International
Covenant on Economic, Social and Cultural Rights (ICESCR) is a
multilateral treaty that the U.N. Member States adopted in 1966.146
Article 12 provides for the right to the "highest attainable standard of
physical and mental health."'147 Although the U.N. General Comment 14
discussing this provision alludes to both the "freedoms and
entitlements" of individuals as patients, it does not include detailed
discussion of patients' rights or medical tourism's implications. 
1 48
While these two key documents are the most relevant to patients'
rights, by themselves they are insufficient protection. The ICPR would
be a first step to filling these gaps. The ICPR drafting process would
mirror the methods used in creating international legislation. An
international commission supervised by the U.N. would draft it; the
U.N. and individual countries would then adopt or reject it.14 9 Similarly
to the UDHR, the ICPR would hopefully be highly influential and would
provide a basis for crafting future international agreements. In this
way, the ICPR would rely on a collaborative international drafting
process to influence unilateral and multilateral efforts to globally
regulate health care.
B. Economic Benefits
From an economic standpoint, the ICPR would help maintain
medical tourism's benefits, more fairly allocate its accompanying risks,
and promote efficiency. While globalization has bolstered medical
tourism through diffusion of medical knowledge, training, and
technology, standardization has not kept pace with globalization. 150 The
ICPR would give notice to concerned parties of their rights and duties,
including patients, physicians, health care facilities, and brokers. In
turn, providing global standards for patients' rights would conserve
resources by eliminating the need for individual health care providers,
146. See generally International Covenant on Economic, Social and Cultural Rights,
Dec. 16, 1966, S. Treaty Doc. No. 95-19, 6 I.L.M. 360 (1967), 993 U.N.T.S. 3. In 1976, the
ICESCR was ratified by 162 countries and was signed but not ratified by an additional 7,
including the United States. Id.
147. Id. at art. 12. The ICESCR discusses the right health care in Article 12 with
accompanying explanation in U.N. Comment 14. U.N. Committee on Economic, Social and
Cultural Rights, General Comment 14, The Right to the Highest Attainable Standard of
Health, U.N. Doc. E/C.12/2000/4 (Aug. 11, 2000), available at http://www.un.orgl
documents/ecosocldocs/2001/e2001-22.pdf [hereinafter U.N. General Comment 14].
148. U.N. General Comment 14, supra note 148, at 130, 8.
149. See infra Section VI.B.1.
150. Cortez, Patients Without Borders, supra note 27, at 131.
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brokers, and medical tourism trade groups to create their own varied
sets of patients' rights. 151
In addition, the ICPR would fulfill a role for destination countries
similar to that which the JCI fulfills in providing private sector
accreditation of individual health care facilities. 152 Destination countries
wishing to expand their medical tourism industries would have an
economic incentive to adopt the ICPR as a means of assuring patients
that their rights will be protected.
C. Protecting Patients and the Integrity of the Medical Profession
Furthermore, the ICPR would protect patients' rights to autonomy
and informed consent by promoting transparency and patient access to
information. It would increase efficiency through provisions delineating
appropriate legal procedures in different circumstances of medical
malpractice. 153 In this way, patients and their domestic physicians could
identify relevant patient rights and be more informed when weighing
the costs and benefits of medical tourism, producing benefits similar to
other proposals involving "information forcing" interventions.154
Finally, increasing transparency by specifying patients' rights is
essential to the policy goal of protecting patients and the integrity of the
medical profession. The physician-patient relationship is rooted in trust
and respect. 55 Physicians trust patients to fully disclose their medical
information and come to them with questions, while respecting patients'
rights to be involved in medical decisions. "56 Patients trust physicians to
act in their best interests, including giving them information necessary
to consent to treatment. 57 In medical tourism, these expectations are
often unclear due to varying quality standards, gaps in communication,
151. Some destination country health care providers, brokers, and industry trade groups
have set out their own lists of patient rights, which tend to be brief and avoid any in-depth
discussion of the substance of the rights. See, e.g., Patient's Bill of Rights, MEDRETREAT,
http://www.medretreat.com/medical-tourism/patient s-billofrights.html (last visited
Nov. 27, 2014); World Med. Assembly, WMA Declaration of Lisbon on the Rights of the
Patient, WORLD MED. ASS'N (Oct. 2005), available at http://www.wma.net/en
30publications/10policies/14/.
152. See Williams, supra note 17, at 633.
153. See infra Section V.B.4.
154. See supra Section III.C.
155. See generally CARL E. SCHNEIDER, THE PRACTICE OF AUTONOMY 3-5 (1998)
(discussing the physician-patient relationship and medical decision-making).
156. Id. at 5.
157. Id.
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and cultural barriers. 158 Clarifying patients' rights will remedy these
concerns and promote patient trust in physicians.
V. CONTENT OF THE ICPR
While providing a comprehensive discussion of the ICPR's contents
is beyond the scope of this Note, the following discussion provides a
starting point and highlights important questions that the JCPR should
consider. 159
A. Types of Medical Tourism Treatment Objectives
As envisioned here, the ICPR distinguishes between "approved"
treatment objectives that fall within its purview and "disapproved"
treatment objectives that are not covered by its provisions. Whether a
treatment objective is approved or disapproved is a threshold issue
when addressing patients' rights under the ICPR. While it may
sometimes be difficult to determine which category a particular
treatment objective falls into, most cases can be categorized based on
widespread support or acceptance either for or against a particular
treatment. As new medical treatments emerge, the ICPR will consider
and categorize each particular treatment.
1. Approved
Treatments that are legal in both the home and destination
countries are approved under the ICPR. Patients seeking these services
generally do so to save money. Examples of incontestably approved
medical tourism include common cardiac procedures and surgeries,
other nonemergency surgical care, cosmetic surgery, and in many cases
fertility treatments and alternative or holistic medicine. 160
Treatments that are legal in both the home and destination
countries but are subject to restricted access in the home country are
158. See Cortez, Recalibrating Risks, supra note 20, at 3.
159. The terms "treatment" and "treatment objective" are used interchangeably, though
it should be noted that in some circumstances the treatment objective, rather than the
procedure itself, is really at issue in determining whether a procedure will be approved or
disapproved.
160. Cf. Bennie, supra note 19, at 584 (discussing common procedures sought by medical
tourism patients). Because of the awareness and acceptance of medical tourists commonly
seeking these types of procedures, these procedures have attained public acceptance and
thus should be treated as incontestably approved types of medical tourism.
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also approved. This includes treatments inaccessible to patients within
specific demographic groups, such as IVF cycles that are inaccessible to
patients who are unmarried,161 in same-sex relationships,162 or past a
certain age. 163 In addition, many treatments prohibited in the home
country but approved in the destination country are also approved.
"Circumvention tourism" may include both outright illegal treatments
as well as experimental treatments that have not yet been approved in
the home country. 64  Examples include controversial stem-cell
therapies, experimental drugs and procedures, and some forms of
reproductive tourism. 165
2. Disapproved
Patients seeking disapproved treatment objectives are not protected
under the ICPR. Treatments that are prohibited in both the home and
destination countries are disapproved. Even if the destination country
does permit the treatment, widespread global consensus that the
practice should be banned results in disapproval. Examples of
disapproved treatments include transplant tourism where a live donor
sells an organ or part of an organ, such as in the case of a kidney or liver
transplant. 166 Even though one country currently permits the selling of
organs, these treatments are nevertheless disapproved due to concerns
about ensuring voluntariness of donation, the coercion and exploitation
of the poor, and the creation of perverse incentives. 167
161. See C. Michael Hall, Medical and Health Tourism: The Development and
Implications of Medical Mobility, in MEDICAL TOURISM: THE ETHICS, REGULATION, AND
MARKETING OF HEALTH MOBILITY 3, 14 (C. Michael Hall ed., 2013).
162. Id.
163. Id. For example, the National Institute for Health and Care Excellence (NICE) in
the United Kingdom has published guidelines that recommend that IVF treatment should
only be offered to women less than forty-three years of age while Sweden and Denmark
permit patients under forty-two and forty-six, respectively. See IVF: Introduction, U.K.
NAT'L HEALTH SERVICES, http://www.nhs.uk/conditions/IVF/Pages/Introduction.aspx (last
updated Jan. 6, 2015); Having IVF Abroad Through Medical Tourism, U.K. HEALTH CTR.
(Sept. 14, 2015), http://www.healthcentre.org.uk/fertility-treatment/ivf-abroad.html.
164. See Williams, supra note 17, at 620.
165. Id.
166. See generally Council on Ethical & Judicial Affairs, Am. Med. Ass'n, Financial
Incentives for Organ Procurement, 155 ARCHIVES INTERNAL MED. 581 (1995) (discussing
how selling kidneys for cash on open market can lead to exploitation of the poor and raises
issues of ensuring voluntariness, and thus should be prohibited).
167. See id. Because the sale of organs for profit is currently only legal in Iran, there is a
booming black market for kidneys in countries such as India and China. See, e.g., Saeed
Kamali Dehghan, Kidneys for Sale: Poor Iranians Compete to Sell their Organs, GUARDIAN
(May 27, 2012, 3:00 PM), http://www.theguardian.com/world/2012/may/27/iran-legal-
trade-kidney; Denis Campbell & Nicola Davison, Illegal Kidney Trade Booms as New
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Other controversial procedures that do not provide therapeutic
benefits to patients are also disapproved. For example, medical tourism
for cultural practices like female genital cutting that are banned in a
patient's home country would not be covered by the ICPR. Likewise,
"death tourism," where patients travel abroad for physician-assisted
suicide, is disapproved.
B. Patients'Rights
For approved treatments, the ICPR would protect patients' rights
and impose obligations on other parties to uphold these rights, including
domestic and foreign health care providers, broker companies, and
government actors. Four interrelated categories of patients' rights
include the right to information, agency, continuity of care, and legal
redress for medical malpractice.
1. Right to information: Informed Consent
The ICPR recognizes patients' right to information and informed
consent before receiving treatment. Rooted in well-established
fundamental human rights to bodily integrity and self-determination, 168
informed consent is the cornerstone of the physician-patient
relationship based on trust16 9 and ensures patients' ability to exercise
agency in decision-making. 170 This right to be informed imposes a
corresponding duty to disclose on the treating physician. 17 1
In keeping with widely accepted standards, the ICPR protects
patients' right to be informed of treatment risks, benefits, and side
effects as well as alternatives before consenting. 172 The ICPR requires
physicians to disclose material information that a reasonable patient
Organ is 'Sold Every Hour, GUARDAN (May 27, 2012, 3:00 PM),
http://www.theguardian.com/world/2012/may/27/kidney-trade-illegal-operations-who.
168. Note, Restructuring Informed Consent: Legal Therapy for the Doctor-Patient
Relationship, 79 YALE L.J. 1533, 1555 (1970) ("According to law, consent is the mechanism
by which the patient grants the physician the power to act and which theoretically
protects the patient against limitations of his freedom and invasions of his person.")
[hereinafter Restructuring Informed Consent].
169. See Marc D. Ginsberg, Informed Consent: No Longer Just What the Doctor Ordered?
The "Contributions" of Medical Associations and Courts to a More Patient Friendly
Doctrine, 15 MICH. ST. U. J. MED. & L. 17, 20-21 (2010).
170. Restructuring Informed Consent, supra note 170, at 1534.
171. Ginsberg, supra note 169, at 27.
172. See id.
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would want to know. 173 While globalization has increased knowledge
sharing and treatment standardization, the medical technology and
professional standards are far from uniform, making a "reasonable
physician" standard less desirable. Although the "reasonable patient" is
subject to cultural variation, it is preferable to rely on this patient-
protective standard because patients are vulnerable consumers who are
generally less informed than physicians. The ICPR adopts a universal
approach that is as close to the "reasonable patient" standard as
possible, and when in doubt, falls back on the "reasonable patient"
standard of whichever country, home or destination, has the more
patient-protective approach.
Furthermore, the unique context of medical tourism requires that
health care providers and physicians disclose certain additional risks
along with those risks of a particular treatment. As discussed above,
medical tourists are especially vulnerable to being uninformed. They
often do not meet the treating physician personally until days before a
procedure and may lack knowledge about the accreditation and quality
standards of their treatment facility. Informed consent might also
require health care providers to disclose information about hospital
accreditation, physician certification, potential difficulties in obtaining
follow-up care, and limitations on medical malpractice before agreeing
to treat patients.
2. Right to Exercise Agency
Under the ICPR, patients' right to agency is closely linked to the
right to informed consent as well as rights to bodily integrity and
autonomy.174 When discussing patients' rights, it is more appropriate to
use the term agency rather than autonomy because not all patients
desire to independently make every important medical decision relating
173. Some U.S. jurisdictions require physicians to disclose what a reasonable physician
in a similar situation would disclose, see Michael Rohde, Information Overload: How the
Wisconsin Supreme Court Expanded the Doctrine of Informed Consent, 46 J. MARSHALL L.
REV. 1097, 1101-02 (2013), while others require disclosure of what a reasonable patient
would want to know, see Ginsberg, supra note 169, at 27.
174. See SCHNEIDER, supra note 155, at 7 ("[A] physician's role is to use his or her
training, knowledge, and experience to provide the patient with facts about the diagnosis
and about the prognoses without treatment and with alternative treatments. The patient's
role in this division of labor is to provide the values-his or her own conception of the
good-with which to evaluate these alternatives, and to select the one that is best for
himself or herself.") (quoting Dan W. Brock, The Ideal of Shared Decision Making Between
Physicians and Patients, 1 KENNEDY INST. ETHICS J. 28, 28 (1991)).
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to their treatment. 175 For some patients, exercising agency means
having sufficient information to choose a treatment; for others, it means
having sufficient information to decide they wish to defer to the
physician's expertise. Medical tourists often have already exercised
considerably agency in seeking treatment abroad. Nevertheless,
treating physicians should be cautious and should not assume that
patients will continue making all medical decisions, as the patients may
wish to have more guidance or defer to physicians. Moreover, physicians
treating international patients must be sensitive to cultural differences
in how patients exercise agency.
Patients' agency also includes the right to control who can access
medical information. Accordingly, physicians should keep medical
information confidential unless the patient consents to disclosure, or
unless there is a pressing public interest at stake. Given the global
reach of medical tourism, protecting patients' control of their medical
information across borders is especially important. All health care
providers and physicians should have procedures for maintaining
confidentiality in place.
3. Right to Continuity of Care
The ICPR also protects patients' rights to continuity of health care.
The physician may not discontinue treatment as long as it is medically
necessary without giving a patient sufficient time and assistance in
finding alternative care. 176 The right to continuity of care also obligates
the physician to cooperate in coordinating with other health care
providers to ensure treatment continuity. 177
Medical tourism can make it difficult to ensure continuity of care
when patients need follow-up care on returning home, whether they
simply require check-ups or encounter unanticipated complications. As
discussed above, patients obtaining treatment in their home countries
can have an ongoing relationship with their physicians. By contrast,
175. While the scholarly discourse on agency versus autonomy paradigms is ongoing,
the agency paradigm has gained broad-based support and is more appropriate for the
purposes of the ICPR. See, e.g., id. at 5 (discussing negative results of the patient
autonomy paradigm as a way that some doctors pass "burdensome problems to patients...
• [wihether because of fear or because of indifference, overwork, or diffidence, physicians
may be prepared to abdicate responsibility for some decisions to patients.")
176. See AMA Code of Med. Ethics, Op. 10.01 (1992), available at http://www.ama-
assn.orglamapub/physician-resources/medical-ethics/code-medical-
ethics/opinionl00l.page?. (discussing the fundamental elements of the patient-physician
relationship, which states that the patient has a right to continuity of care and is an
essential part of the patient-physician relationship).
177. See id.
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medical tourists cannot easily access their treating physicians and often
struggle to obtain follow-up care due to financial constraints or
physicians who are unwilling to see them.
While these challenges seem inherent to medical tourism, imposing
standards on overseas health care providers through the ICPR puts
patients in the best position possible to obtain health care on return.
Physicians and health care providers must alert patients to the
difficulties they may encounter following treatment abroad and either
help patients to form a plan for anticipated and unanticipated follow-up
treatment or, at the very least, inform patients that they should do so
on their own.
4. Right to Legal Redress: Medical Malpractice in Medical Tourism
The ICPR would protect patients' right to legal redress for medical
malpractice. To ensure that patients have access to legal redress, the
ICPR would prohibit health care providers from requiring patients to
waive medical malpractice claims and outline the appropriate procedure
for bringing these claims.
As discussed above, perhaps one of the most serious risks for
medical tourists is that other countries may restrict legal redress for
medical malpractice.178 A complicating factor is that different countries
approach medical malpractice in different ways, and the legal systems
of major destination countries tend to be less patient-centered than
those of more developed home countries. 79 Because the public interests
in protecting vulnerable patients and more fairly allocating legal risks
of medical care persist in the context of medical tourism, the ICPR holds
waivers of medical malpractice to be unenforceable.180 In addition to
protecting patients, this prohibition on medical malpractice waivers will
increase efficiency by delineating liability at the outset, rather than
requiring individual providers to create their own standards.
In addition, the ICPR proposes appropriate procedures for patients
to bring medical malpractice claims. First, for medical malpractice
involving approved treatments and procedures that are legal in both the
178. See supra Section II.B.
179. For example, several major destinations for medical tourists routinely use and
enforce medical malpractice waivers that would be void as against public policy in the
United States. See Cohen, Protecting Patients, supra note 17, at 1528-29 (discussing the
development and justification for the prohibition on medical malpractice waivers in the
United States).
180. See Cortez, Recalibrating Risks, supra note 20, at 88-89 (discussing how
prohibiting waivers would help to "reallocate more fairly the legal risks of medical
travel").
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home and destination countries, patients should be able to bring a
medical malpractice claim in whichever country they choose. If and
when choice of law issues arise, courts should adopt the law of the
country most favorable to patients.18 '
Allowing these patients to choose either the home or destination
country forum more fairly allocates the risk of medical malpractice by
placing the burden of coming to the patient's chosen forum on health
care providers and physicians. While this approach may result in
expense and inconvenience to providers, these risks create incentives for
providers to be more careful and guard against negligence, which
benefits medical tourists. Furthermore, health care providers are better
positioned financially to bear these costs than vulnerable patients who
often seek treatment internationally because they cannot afford
domestic care. 182
Patients who engage in circumvention tourism for approved
treatments are also entitled to legal redress. These patients, however,
should have less flexibility in bringing their claims, and should seek a
remedy from the destination country's legal system. For example, a
patient from Ireland who circumvents domestic laws prohibiting
abortion and travels to the United Kingdom for an abortion should bring
a medical malpractice claim in the United Kingdom in the event of
malpractice. Destination country health care providers should ensure
that, as part of the informed consent process, patients are made aware
of these legal limitations as well as resources for bringing medical
malpractice claims in the destination country.
Finally, patients who engage in medical tourism to obtain
disapproved treatment are not guaranteed legal redress under the
ICPR. This lack of protection should discourage patients seeking these
treatments overseas.
VI. LOOKING FORWARD
A. Areas for Further Consideration
In addition to determining whether a particular procedure is
approved or disapproved, the ICPR may also provide more guidance for
specific types of treatments. Reproductive tourism, including surrogacy,
abortion, and IVF, is a large and growing segment of medical tourism
that would benefit from specific provisions addressing the various
181. See generally Howze, supra note 8, at 1038 (explaining how "choice of law"
scenarios and outcomes affect plaintiffs in U.S. courts).
182. See supra Section I.B.
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parties' legal rights and duties. For example, unlike nonreproductive
health care that involves the rights of a single patient, surrogacy
tourism implicates the rights of the mother, father, gamete donors,
surrogate, and child.'8 3
Another issue for further consideration is how the ICPR should
regulate quality of patient care. Transparency, mandatory disclosure,
and informed consent may not suffice to ensure adequate quality
control. Mandatory accreditation for providers may be called on to fill
this gap.
Furthermore, additional planning is needed to determine the ICPR's
content and structure and to consider how it might work in tandem with
existing private sector regulation. Taking advantage of existing
structures can ensure efficient and effective ICPR adoption. For
example, maintaining established private sector accreditation processes
through entities like the JCI, augmented by governmental oversight,
may accomplish some ICPR aims.18 4 Moreover, inviting feedback from
participants in the medical tourism industry such as patients, brokers,
and destination country physicians and hospitals will help to identify
additional concerns and craft an ICPR that will maintain the medical
tourism's benefits without exposing patients to unfair risks.
B. Addressing Possible Criticism
1. Is Global Enforcement of the ICPR Unrealistic?
One possible criticism of the ICPR is that global enforcement is
unrealistic because individual countries would have to independently
ratify, adopt, and enforce ICPR provisions for it to be effective.
Nevertheless, existing international instruments protecting individual
rights illustrate that such initiatives can have a far-reaching impact on
the global community and, as a minimum, lay a foundation for reform.
The UDHR and ICESCR provide a helpful model for the ICPR in terms
of drafting and global impact. For example, although the UDHR is not a
legally binding treaty, the multilateral drafting process and U.N.
adoption has allowed it to be highly influential, and it is widely accepted
183. See generally Pamela Laufer-Ukeles, Mothering for Money: Regulating Commercial
Intimacy, 88 IND. L.J. 1223, 1248-49 (2013) (discussing how the rights of each parties
should influence the commercialization of surrogacy agreements); Caitlin Pyrce,
Surrogacy and Citizenship: A Conjunctive Solution to a Global Problem, 23 IND. J. GLOBAL
LEGAL STUD. 925 (2016).
184. See Williams, supra note 17, at 680.
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as part of customary international law. 185 Furthermore, the UDHR has
formed the basis for multilateral agreements like the ICESCR.186
Similarly, an international commission of governmental and
nongovernmental actors would draft the ICPR, which would then be
submitted for adoption by the U.N. Individual states would also be
encouraged to adopt the ICPR in keeping with the general aims of
protecting human rights set out in the UDHR. In addition, the ICPR
would lay the foundation for future international agreements. Through
this process, a variety of viewpoints would shape the ICPR and the
drafting process would invite comment from the global community. This
global approach would enhance the ICPR's credibility, increase its
pragmatic effectiveness, and provide a basis for building a more holistic
regulatory framework in the future.
2. Do the Costs of the ICPR Outweigh the Benefits?
Critics may question the ICPR's viability on the grounds that
protecting patient rights will be prohibitively costly, hinder trade, and
render the ICPR impracticable. 8 7 But the ICPR's burdens do not render
it ineffective; on the contrary, they represent worthwhile investments in
regulating medial tourism.
For example, upholding patient rights pursuant to the ICPR
imposes obligations on physicians and other health care providers. For
domestic health care providers, recognizing these patient rights may
create an obligation to inform patients of the option of medical travel as
a possible alternative to domestic treatment. The right to continuity of
care for medical tourists imposes a burden on domestic providers as
well. Meanwhile, physicians and hospitals in destination countries will
assume the burdens of upholding patient rights under the ICPR and
expend additional time and resources sharing information with patients
to obtain informed consent. In instances of medical malpractice,
overseas providers may incur expenses if they have to change
established practices of forcing patients to sign waivers or travel to a
patient's home country for legal proceedings.
185. Digital Record of the UDHR, supra note 144 (asserting that the UDHR is "widely
regarded as forming part of customary international law"). See also Hannum, supra note
144, at 289 ("The Universal Declaration of Human Rights has been the foundation of
much of the post- 1945 codification of human rights").
186. See generally John P. Humphrey, The Universal Declaration of Human Rights: Its
History, Impact and Juridical Character, in HUMAN RIGHTS: THIRTY YEARS AFTER THE
UNIVERSAL DECLARATION 21 (B.G. Ramcharan ed., 1979).
187. As one critic of multilateral regulation points out, "[tihe general purpose of
international law ... is to enhance, not impede, trade between nations." Williams, supra
note 17, at 657.
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Nonmedical participants will also likely incur expenses. For
example, broker companies will be required to eliminate blanket
waivers and will be held to higher standards in selecting destination
countries and facilities that conform to the ICPR.188 Moreover, the legal
systems in both home and destination countries will expend time and
resources processing increased medical malpractice litigation. Finally,
patients themselves will bear the burden of upholding the ICPR. As the
medical tourism industry adjusts to these requirements, costs may shift
to patients as consumers. These additional costs may decrease the cost-
saving benefits of traveling abroad for medical care.
Nevertheless, the costs of the ICPR do not outweigh its holistic,
long-term benefits. While establishing and upholding the ICPR will be
expensive initially, these costs are a worthwhile investment in
protecting patients' rights since they uphold the integrity of the medical
profession, promote justice, and set the stage for effective future
regulation.
CONCLUSION
The emergence of medical tourism in recent years demonstrates
globalization's far-reaching impact on health care. While this industry's
rapid expansion has offered life-changing benefits to patients who might
otherwise be unable to access or afford certain treatments, medical
tourism has also introduced unprecedented risks, including quality-of-
care concerns and inadequate legal redress for malpractice.
Furthermore, existing regulations are insufficient to protect patients
against potential pitfalls. This Note proposes the creation of the ICPR to
more effectively preserve the benefits of medical tourism while
minimizing its risks. Regulation of medical tourism through the ICPR
will ensure that it is sustainable by preventing the victimization of
patients by medical negligence and imposing uniform standards that
participating countries all take part in creating. Without the ICPR,
regulation will be a complicated and contradictory system of piecemeal
regulations from country to country. As the global industry of medical
tourism continues to develop, regulation through the ICPR is a key part
of what must be a continued collaborative effort to promote the
availability of quality health care through holistic regulation that
upholds patient rights.
188. See Leigh G. Turner, Quality in Health Care and Globalization of Health Services:
Accreditation and Regulatory Oversight of Medical Tourism Companies, 23 INT'L J.
QUALITY HEALTH CARE 1, 4-5 (2010) (arguing in favor of limiting waivers on medical
malpractice in medical tourism and listing the standards expected of such brokers).
